Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway

Cancer Letters(2021)10.1016/j.canlet.2021.09.041Source: DataRank Database

MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway is a research paper published in Cancer Letters (2021). On theSindex it has a DataRank of 0.609. It has been cited 57 times.

N/A

0.609DataRank · unranked

Scored on demand from live citation data

Open Access57 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (20)Linked Datasets (14)DataCite Reuse (14)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.609

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (16)

Guoliang Li ORCID,Tian Shen ORCID,Nataliya Gladoun ORCID,Mireia Castillo-Martín ORCID,Sherly I. Celada ORCID

Live enrichment

PubMed:34610416 PMC:PMC12419200

National Institutes of Health

Grant: S10RR0254970

National Institutes of Health

Grant: U54CA163069

National Institutes of Health

Grant: U54MD007586

National Institutes of Health

Grant: U54MD007593

National Institutes of Health

Grant: UL1TR000445-06

NCATS NIH HHS

Grant: UL1 TR000445

Wellcome Trust

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12419200/

publisherhttps://api.elsevier.com/content/article/PII:S0304383521005024?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383521005024?httpAccept=text/plain

MeSH Terms

AnimalsHumansMiceProstatic NeoplasmsDisease ProgressionAcetyl-CoA CarboxylaseMicroRNAsSignal TransductionCell ProliferationGene Expression Regulation, NeoplasticMaleSterol Regulatory Element Binding Protein 1Insulin Receptor Substrate ProteinsFatty Acid Synthase, Type IHeterografts

Keywords

ACCPTENFasnTp53Fatty Acid Signaling And Mouse Models

Additional file 2 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563950.v1figshare

Additional file 2 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563950figshare

Additional file 3 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563953.v1figshare

Additional file 3 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563953figshare

Additional file 4 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563956.v1figshare

Additional file 4 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563956figshare

Additional file 5 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563959.v1figshare

Additional file 5 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563959figshare

Additional file 6 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563962.v1figshare

Additional file 6 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563962figshare

Additional file 7 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563965.v1figshare

Additional file 7 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563965figshare

Additional file 1 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563947.v1figshare

Additional file 1 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563947figshare